Clinical trials: Rectal Cancer Recurrent, open to volunteers
Rectal Cancer, Rectal Adenocarcinoma
Advanced Endoscopic Resections for Rectal Neoplasms
This study evaluates how advanced endoscopic resection techniques affect treatment outcomes in adults with rectal cancer. Rectal cancer has traditionally been treated with standard abdominal surgery.
- Conditions
- Rectal Cancer, Rectal Adenocarcinoma, Rectal Adenoma, Rectal Neuroendocrine Neoplasm
- Trial name
- NCT07410767
- Testing
- Endoscopic submucosal dissection, Endoscopic intramuscular dissection
- Where
- Poland
- Volunteers
- 300 people
- Sponsor
- Jagiellonian University
Colorectal Neoplasms, Colorectal Cancer
DANISH.MRD: Danish Assessment of Minimal Residual Disease by Liquid Biopsies
Approximately two-thirds of all colorectal cancer patients undergo surgery with the aim of curing them. However, despite the surgery, 20-25% of them experience relapse.
- Conditions
- Colorectal Neoplasms, Colorectal Cancer, Colorectal Adenocarcinoma, Colorectal Cancer Stage I
- Trial name
- NCT06076811
- Where
- 10 sites in Denmark
- Volunteers
- 1,600 people
- Sponsor
- University of Aarhus
Colorectal Neoplasms
SBRT Followed by PD-1 Inhibitor, Bevacizumab and TAS-102 as Third-Line Therapy for Recurrent/Metastatic Colorectal Cancer
This phase II trial studies how well stereotactic body radiotherapy (SBRT) followed by a combination of an immune checkpoint inhibitor (sintilimab), bevacizumab, and trifluridine/tipiracil (TAS-102) works as third-line treatment…
- Trial name
- BEST (NCT07535632)
- Testing
- SBRT, Sintilimab, Bevacizumab
- Where
- China
- Volunteers
- 58 people
- Sponsor
- Shanghai Zhongshan Hospital
Unresectable Locally Recurrent Rectal Cancer
SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）
This is a prospective study to delve into the therapeutic benefits of combining stereotactic body radiation therapy (SBRT) with PD-1 monoclonal antibody treatment for patients with unresectable locally recurrent rectal cancer…
- Trial name
- NCT06767007
- Testing
- Stereotactic Body Radiation Therapy (SBRT), PD1, Chemotherapy
- Where
- China
- Volunteers
- 31 people
- Sponsor
- Sixth Affiliated Hospital, Sun Yat-sen University